Your browser doesn't support javascript.
Real-life use of remdesivir in hospitalized patients with COVID-19.
Garcia-Vidal, C; Meira, F; Cózar-Llistó, A; Dueñas, G; Puerta-Alcalde, P; Garcia-Pouton, N; Chumbita, M; Cardozo, C; Hernandez-Meneses, M; Alonso-Navarro, R; Rico, V; Agüero, D; Bodro, M; Morata, L; Jordan, C; Lopera, C; Ambrosioni, J; Segui, F; Grafia, N; Castro, P; García, F; Mensa, J; Martínez, J A; Sanjuan, G; Soriano, A.
  • Soriano A; Dr. Alex Soriano, Department of Infectious Diseases, Hospital Clinic of Barcelona, C/ Villarroel 170, 08036 Barcelona, Spain. asoriano@clinic.cat.
Rev Esp Quimioter ; 34(2): 136-140, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1119722
ABSTRACT

OBJECTIVE:

Controversial results on remdesivir efficacy have been reported. We aimed to report our real-life experience with the use of remdesivir from its availability in Spain.

METHODS:

We performed a descriptive study of all patients admitted for ≥48 hours with confirmed COVID-19 who received remdesivir between the 1st of July and the 30th of September 2020.

RESULTS:

A total of 123 patients out of 242 admitted with COVID-19 at our hospital (50.8%) received remdesivir. Median age was 58 years, 61% were males and 56.9 % received at least one anti-inflammatory treatment. No adverse events requiring remdesivir discontinuation were reported. The need of intensive care unit admission, mechanical ventilation and 30-days mortality were 19.5%, 7.3% and 4.1%, respectively.

CONCLUSIONS:

In our real-life experience, the use of remdesivir in hospitalized patients with COVID-19 was associated with a low mortality rate and good safety profile.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / COVID-19 Drug Treatment / Inpatients Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Rev Esp Quimioter Journal subject: Drug Therapy Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / COVID-19 Drug Treatment / Inpatients Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Rev Esp Quimioter Journal subject: Drug Therapy Year: 2021 Document Type: Article